
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Modulation of antigen presenting cell functions during chronic HPV infection
Abate Assefa Bashaw, Graham R. Leggatt, Janin Chandra, et al.
Papillomavirus Research (2017) Vol. 4, pp. 58-65
Open Access | Times Cited: 63
Abate Assefa Bashaw, Graham R. Leggatt, Janin Chandra, et al.
Papillomavirus Research (2017) Vol. 4, pp. 58-65
Open Access | Times Cited: 63
Showing 1-25 of 63 citing articles:
Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System
Chenhao Zhou, Zewen Kelvin Tuong, Ian H. Frazer
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 185
Chenhao Zhou, Zewen Kelvin Tuong, Ian H. Frazer
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 185
Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk
Rehana Hewavisenti, Joshua Arena, Chantelle Ahlenstiel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 60
Rehana Hewavisenti, Joshua Arena, Chantelle Ahlenstiel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 60
Trial watch: dendritic cell vaccination for cancer immunotherapy
Jenny Sprooten, Jolien Ceusters, An Coosemans, et al.
OncoImmunology (2019) Vol. 8, Iss. 11, pp. 1638212-1638212
Open Access | Times Cited: 134
Jenny Sprooten, Jolien Ceusters, An Coosemans, et al.
OncoImmunology (2019) Vol. 8, Iss. 11, pp. 1638212-1638212
Open Access | Times Cited: 134
Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge
Ena Pešut, Anamaria Đukić, Lucija Lulić, et al.
Viruses (2021) Vol. 13, Iss. 11, pp. 2234-2234
Open Access | Times Cited: 58
Ena Pešut, Anamaria Đukić, Lucija Lulić, et al.
Viruses (2021) Vol. 13, Iss. 11, pp. 2234-2234
Open Access | Times Cited: 58
Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection
Lungelo Ntuli, Andile Mtshali, Gugulethu Mzobe, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 49
Lungelo Ntuli, Andile Mtshali, Gugulethu Mzobe, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 49
Activities of stromal and immune cells in HPV-related cancers
Marconi Rêgo Barros Júnior, Cristiane Moutinho Lagos de Melo, Maria Luiza Carneiro Moura Gonçalve Barros, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 70
Marconi Rêgo Barros Júnior, Cristiane Moutinho Lagos de Melo, Maria Luiza Carneiro Moura Gonçalve Barros, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 70
The Host-Microbe Interplay in Human Papillomavirus-Induced Carcinogenesis
Rei Wakabayashi, Yusuke Nakahama, Nguyễn Hoàng Việt, et al.
Microorganisms (2019) Vol. 7, Iss. 7, pp. 199-199
Open Access | Times Cited: 63
Rei Wakabayashi, Yusuke Nakahama, Nguyễn Hoàng Việt, et al.
Microorganisms (2019) Vol. 7, Iss. 7, pp. 199-199
Open Access | Times Cited: 63
HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer
Sayuri Miyauchi, P. Dominick Sanders, Kripa Guram, et al.
Cancer Research (2019) Vol. 80, Iss. 4, pp. 732-746
Open Access | Times Cited: 56
Sayuri Miyauchi, P. Dominick Sanders, Kripa Guram, et al.
Cancer Research (2019) Vol. 80, Iss. 4, pp. 732-746
Open Access | Times Cited: 56
The role of HPV‑induced epigenetic changes in cervical carcinogenesis (Review)
Martha Da Silva, Beatriz De Albuquerque, Thales Allyrio, et al.
Biomedical Reports (2021) Vol. 15, Iss. 1
Open Access | Times Cited: 54
Martha Da Silva, Beatriz De Albuquerque, Thales Allyrio, et al.
Biomedical Reports (2021) Vol. 15, Iss. 1
Open Access | Times Cited: 54
The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers
Shiyu Qi, Miaomiao Yang, Chong-Yang Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Shiyu Qi, Miaomiao Yang, Chong-Yang Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
HPV and the Risk of HIV Acquisition in Women
Romaniya Zayats, Thomas T. Murooka, Lyle R. McKinnon
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 28
Romaniya Zayats, Thomas T. Murooka, Lyle R. McKinnon
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 28
Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients
Soumik Das, Achsha Babu, Tamma Medha, et al.
Medical Oncology (2023) Vol. 40, Iss. 5
Open Access | Times Cited: 14
Soumik Das, Achsha Babu, Tamma Medha, et al.
Medical Oncology (2023) Vol. 40, Iss. 5
Open Access | Times Cited: 14
Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers
Marconi Rêgo Barros Júnior, Talita Helena Araújo de Oliveira, Cristiane Moutinho Lagos de Melo, et al.
Journal of Immunology Research (2018) Vol. 2018, pp. 1-17
Open Access | Times Cited: 41
Marconi Rêgo Barros Júnior, Talita Helena Araújo de Oliveira, Cristiane Moutinho Lagos de Melo, et al.
Journal of Immunology Research (2018) Vol. 2018, pp. 1-17
Open Access | Times Cited: 41
Immunotherapy for HPV associated cancer
Ian H. Frazer, Janin Chandra
Papillomavirus Research (2019) Vol. 8, pp. 100176-100176
Open Access | Times Cited: 38
Ian H. Frazer, Janin Chandra
Papillomavirus Research (2019) Vol. 8, pp. 100176-100176
Open Access | Times Cited: 38
Immunology of HPV-mediated cervical cancer: current understanding
Babban Jee, Renu Yadav, Sangeeta Pankaj, et al.
International Reviews of Immunology (2020) Vol. 40, Iss. 5, pp. 359-378
Closed Access | Times Cited: 37
Babban Jee, Renu Yadav, Sangeeta Pankaj, et al.
International Reviews of Immunology (2020) Vol. 40, Iss. 5, pp. 359-378
Closed Access | Times Cited: 37
Co-Infection and Cancer: Host–Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses
Tania Mulherkar, Daniel Joseph Gómez, Grace Sandel, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 2037-2037
Open Access | Times Cited: 22
Tania Mulherkar, Daniel Joseph Gómez, Grace Sandel, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 2037-2037
Open Access | Times Cited: 22
Advances in immunotherapy for gynecological malignancies
Mengyan Tu, Junfen Xu
Critical Reviews in Oncology/Hematology (2023) Vol. 188, pp. 104063-104063
Closed Access | Times Cited: 10
Mengyan Tu, Junfen Xu
Critical Reviews in Oncology/Hematology (2023) Vol. 188, pp. 104063-104063
Closed Access | Times Cited: 10
Curdione combined with borneol treats bacterial mixed HPV infection by regulating the crosstalk among immune cells
Jingwei Liu, Tong Shu, Yulian Mu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Jingwei Liu, Tong Shu, Yulian Mu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Sexually transmitted human papillomavirus and related sequelae
Wyatt Hanft, Helen C. Stankiewicz Karita, Nikka Khorsandi, et al.
Clinical Microbiology Reviews (2025)
Closed Access
Wyatt Hanft, Helen C. Stankiewicz Karita, Nikka Khorsandi, et al.
Clinical Microbiology Reviews (2025)
Closed Access
The promise of PD1/PDL1 targeted immunotherapy in locally advanced cervical cancer: a game-changer for patients outcome?
Fadila Kouhen, Adil El Ghanmi, Hanane Inghaoun, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Fadila Kouhen, Adil El Ghanmi, Hanane Inghaoun, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The value of cytokine levels in triage and risk prediction for women with persistent high-risk human papilloma virus infection of the cervix
Bohan Li, Ling Zhang, Jianguo Zhao, et al.
Infectious Agents and Cancer (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 29
Bohan Li, Ling Zhang, Jianguo Zhao, et al.
Infectious Agents and Cancer (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 29
Oral Papillomatosis: Its Relation with Human Papilloma Virus Infection and Local Immunity—An Update
Elena Andrei, Ileana Monica Baniţă, Maria Cristina Munteanu, et al.
Medicina (2022) Vol. 58, Iss. 8, pp. 1103-1103
Open Access | Times Cited: 15
Elena Andrei, Ileana Monica Baniţă, Maria Cristina Munteanu, et al.
Medicina (2022) Vol. 58, Iss. 8, pp. 1103-1103
Open Access | Times Cited: 15
Dendritic Cells: A Bridge between Tolerance Induction and Cancer Development in Transplantation Setting
Dario Troise, Barbara Infante, Silvia Mercuri, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1240-1240
Open Access | Times Cited: 3
Dario Troise, Barbara Infante, Silvia Mercuri, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1240-1240
Open Access | Times Cited: 3
Human papillomavirus infection affects the immune microenvironment and antigen presentation in penile cancer
Sulayne Janayna Araújo Guimarães, André Álvares Marques Vale, Mirtes Castelo Branco Rocha, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Sulayne Janayna Araújo Guimarães, André Álvares Marques Vale, Mirtes Castelo Branco Rocha, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Indoleamine 2,3‐dioxygenase and tryptophan 2,3‐dioxygenase expression in HPV infection, SILs, and cervical cancer
Paloma Almeida Venancio, Márcia Edilaine Lopes Consolaro, Sophie Derchain, et al.
Cancer Cytopathology (2019) Vol. 127, Iss. 9, pp. 586-597
Open Access | Times Cited: 24
Paloma Almeida Venancio, Márcia Edilaine Lopes Consolaro, Sophie Derchain, et al.
Cancer Cytopathology (2019) Vol. 127, Iss. 9, pp. 586-597
Open Access | Times Cited: 24